BamSEC and AlphaSense Join Forces
Learn More

Bio Green Med Solution, Inc. – Material Contracts

NASDAQ: BGMS    
Share price (7/14/26): $0.91    
Market cap (7/14/26): $4.995 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.2
from 8-K 19 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 33 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 425 3 pages Exhibit F Form of Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 3 pages Exhibit F Form of Lock-Up Agreement
12/34/56
EX-10.1
from 8-K 7 pages Warrant Exchange Agreement
12/34/56
EX-10.1
from 425 9 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm if Publicly Disclosed. Trademark License Agreement
12/34/56
EX-10.1
from 8-K 9 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and Would Likely Cause Competitive Harm if Publicly Disclosed. Trademark License Agreement
12/34/56
EX-10.1
from 8-K 7 pages Warrant Exchange Agreement
12/34/56
EX-10.3
from 8-K 13 pages Amended and Restated Series C Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 13 pages Amended and Restated Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 13 pages Amended and Restated Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.32
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.31
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.30
from S-4 4 pages Director Services Agreement
12/34/56
EX-10.29
from S-4 4 pages Executive Officer and Director Services Agreement
12/34/56
EX-10.28
from S-4 4 pages Executive Officer and Director Services Agreement
12/34/56
EX-10.4
from 8-K 16 pages Series C Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.3
from 8-K 15 pages Series B Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.2
from 8-K 16 pages Series a Common Stock Purchase Warrant Cyclacel Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 38 pages Form of Securities Purchase Agreement
12/34/56